GLOW Blend

What Is GLOW Blend?

GLOW Blend is three peptides co-formulated in a single vial: BPC-157 (a 15-amino-acid pentadecapeptide derived from a human gastric juice protein), TB-500 (the synthetic acetate of the active region of thymosin beta-4), and GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper). The rationale for combining them is that the three act on distinct and complementary repair pathways. BPC-157 drives angiogenesis through the VEGFR2 and nitric oxide axis and accelerates fibroblast migration in gut, tendon, and ligament models. TB-500 sequesters G-actin to enable cell migration into damaged tissue and is most active in muscle and connective-tissue models.

GHK-Cu operates at the transcriptional level, modulating expression of over 4,000 human genes (per the Broad Institute Connectivity Map analysis) toward a younger profile, with dominant effects on collagen I, III, and IV synthesis, MMP/TIMP balance, and copper delivery as a cofactor for lysyl oxidase and superoxide dismutase. No receptor competition or shared transporter has been reported among the three, and each carries decades of independent literature. There is no published trial of the three-way combination itself; the mechanistic rationale is the sum of the individual components' documented effects.